Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
about
Structural mechanism of serum amyloid A-mediated inflammatory amyloidosisDivergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid ASerum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.Characterization of the oligomerization and aggregation of human Serum Amyloid AMyeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Targeting protein aggregation for the treatment of degenerative diseasespH Induced Conformational Transitions in the Transforming Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants.Amyloid and inflammation.Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: a review.Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural InsightsSerum amyloid A1: Structure, function and gene polymorphism.Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
P2860
Q27683023-0C7465B6-2A89-4C91-8478-CFFFC8CEB055Q33993673-2541EDF8-A202-49F9-AAE6-71876F543CB8Q34615520-20F6FC90-A0B5-483C-A6F4-D935F489261EQ34764150-A6F9447C-72EC-4409-BF6A-A6BB7308C725Q35536293-72432B32-7D82-43C6-B806-8EB2710AC4F3Q35886290-71AE4620-C0F1-4674-BD93-F17B459A58C8Q36235980-7C3BEBB3-BF4D-4476-BFAC-EF13505376F5Q36748354-7DBBEA2E-EEC0-46F1-8AB4-B5EFC7D2CE40Q37236611-90D71389-E23E-45B5-99BC-99B1C26EFFDDQ38515389-4C9FABEE-C07A-43F8-A631-3F6616143C92Q38543425-21B1A37B-3F8D-4A29-97BF-68F0B5820D64Q38761950-554788E1-BFF4-43E8-BB05-588C51F20B95Q48028286-331AD85E-3D0D-4F2B-B28A-EAF5C80D4065Q51548302-F00117DD-4D08-45FB-91E3-CED159697D48
P2860
Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@ast
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@en
type
label
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@ast
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@en
prefLabel
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@ast
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@en
P2093
P2860
P356
P1476
Pathogenic serum amyloid A 1.1 ...... dogenic non-pathogenic SAA2.2.
@en
P2093
Dmitry Kurouski
Igor K Lednev
Jeffrey Litt
Maria M Lopez
Ravi S Kane
Saipraveen Srinivasan
Sanket Patke
Sunit K Srivastava
Wilfredo Colón
P2860
P304
P356
10.1074/JBC.M112.394155
P407
P577
2012-12-05T00:00:00Z